We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+12.11%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$95.1B
AUM Growth
+$8.07B
Cap. Flow
-$2.38B
Cap. Flow %
-2.5%
Top 10 Hldgs %
11.63%
Holding
2,696
New
179
Increased
1,230
Reduced
1,050
Closed
159

Sector Composition

Rank Sector Weight
1 Technology 19.1%
2 Industrials 14.14%
3 Financials 12.67%
4 Consumer Discretionary 11.73%
5 Healthcare 9.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACTG icon
2401
Acacia Research
ACTG
$470M
$51.7K ﹤0.01%
13,180
+2,426
+23% +$8.98K
FLUX icon
2402
Flux Power
FLUX
$11.4M
$51.4K ﹤0.01%
+12,516
New +$43.4K
FIP icon
2403
FTAI Infrastructure
FIP
$505M
$51.3K ﹤0.01%
13,200
+2,490
+23% +$8.73K
CERS icon
2404
Cerus
CERS
$474M
$50.9K ﹤0.01%
23,587
+4,314
+22% +$7.11K
ADV icon
2405
Advantage Solutions
ADV
$361M
$50.9K ﹤0.01%
+562
New +$40K
STRR
2406
Star Equity Holdings
STRR
$41.7M
$50.8K ﹤0.01%
+3,263
New +$53.7K
LXRX icon
2407
Lexicon Pharmaceuticals
LXRX
$1.1B
$49.2K ﹤0.01%
32,187
+5,813
+22% +$6.91K
BTBT icon
2408
Bit Digital
BTBT
$482M
$48.2K ﹤0.01%
+11,406
New +$29.8K
CHRS icon
2409
Coherus Oncology
CHRS
$196M
$47.6K ﹤0.01%
14,306
+3,206
+29% +$8.59K
CLOV icon
2410
Clover Health Investments
CLOV
$2.51B
$47.6K ﹤0.01%
49,971
+9,837
+25% +$9.66K
FSR
2411
DELISTED
Fisker Inc.
FSR
$47K ﹤0.01%
26,846
+5,761
+27% +$20.4K
WULF icon
2412
TeraWulf
WULF
$8.52B
$46.9K ﹤0.01%
19,529
+6,408
+49% +$8.73K
EVGO icon
2413
EVgo
EVGO
$229M
$46.8K ﹤0.01%
13,086
+2,406
+23% +$7.13K
FATE icon
2414
Fate Therapeutics
FATE
$326M
$46.8K ﹤0.01%
12,504
+2,322
+23% +$5.48K
FRGE
2415
DELISTED
Forge Global Holdings
FRGE
$46.7K ﹤0.01%
908
+218
+32% +$9.25K
ALLO icon
2416
Allogene Therapeutics
ALLO
$694M
$45.8K ﹤0.01%
14,283
+2,680
+23% +$7.6K
AMWL icon
2417
American Well
AMWL
$230M
$45.5K ﹤0.01%
1,528
+297
+24% +$7.29K
ESPR
2418
DELISTED
Esperion Therapeutics
ESPR
$45.4K ﹤0.01%
15,198
+3,558
+31% +$4.62K
OCUL icon
2419
Ocular Therapeutix
OCUL
$2.02B
$45.2K ﹤0.01%
+10,135
New +$30K
ORGO icon
2420
Organogenesis Holdings
ORGO
$239M
$43.4K ﹤0.01%
+10,621
New +$29.7K
WTI icon
2421
W&T Offshore
WTI
$518M
$42.7K ﹤0.01%
13,086
-10,736
-45% -$39.6K
QVCGA
2422
DELISTED
QVC Group Inc Series A
QVCGA
$41.9K ﹤0.01%
958
+189
+25% +$6.48K
SFIX
2423
Stitch Fix
SFIX
$560M
$41.6K ﹤0.01%
+11,648
New +$41.1K
SES icon
2424
SES AI
SES
$208M
$41.5K ﹤0.01%
22,663
+7,798
+52% +$16.8K
IHRT icon
2425
iHeartMedia
IHRT
$583M
$41.1K ﹤0.01%
15,403
+2,950
+24% +$7.46K

Similar funds

Victory Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Victory Capital Management held 2,696 positions worth $95.1B, up 9.3% from $87B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Victory Capital Management's Q4 2023 filing shows 179 new, 1,230 increased, 1,050 reduced and 159 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 1,608,317 shares worth $124M. The largest sale was Hewlett Packard, an estimated $247M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.

  • Victory Capital Management's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 1,608,317 shares worth $124M.
  • Victory Capital Management added most to Willis Towers Watson in Q4 2023, an estimated $334M increase.
  • Victory Capital Management's biggest Q4 2023 reduction was Hewlett Packard, cutting an estimated $247M.
  • Victory Capital Management fully exited iShares Russell 2000 Growth ETF in Q4 2023, selling an estimated $127M.
  • Victory Capital Management's ten largest holdings make up 12% of its $95.1B portfolio in Q4 2023.
  • Victory Capital Management opened 179 new positions and closed 159 in Q4 2023.
  • Victory Capital Management's portfolio value rose 9.3% quarter-over-quarter to $95.1B.

Based on Victory Capital Management's 13F filing for Q4 2023, filed 5 Feb 2024.